Labor de proyeccion humanitaria de la FILACP. Campaña 2019 / FILACP humanitarian projection work. Campaign 2019

Introducción y objetivo: La Federación Ibero Latinoamericana de Cirugía Plástica (FILACP), como organización internacional de especialistas en Cirugía Plástica, Estética y Reparadora unidos por una lengua común, incentiva la participación de sus cirujanos en campañas de labor humanitaria que, prestando ayuda médica con cirugías de alta complejidad a pacientes de entornos sociales o geográficos menos favorecidos, pueden mejorar su calidad de vida y su integración en la sociedad. Presentamos en este trabajo, a modo de ejemplo de una labor iniciada ya hace años, la desarrollada por los equipos que han participado en la III Jornada Altruista de Cirugía Plástica de la FILACP correspondiente al año 2019. Material y método: La campaña fue convocada desde FILACP a través de su página web, la página de Facebook y el canal de Youtube en redes sociales y mediante cartas enviadas a los delegados de sus Comités Médico Social y de Difusión y a los presidentes de las sociedades nacionales de Cirugía Plástica de los 22 países miembros. Las jornadas de trabajo se desarrollaron durante los meses de julio y agosto de 2019 con equipos quirúrgicos compuestos por cirujanos plásticos, anestesiólogos y personal de enfermería que trabajaron voluntariamente, de forma altruista, y tanto a título personal como apoyados por las instituciones sanitarias en las que habitualmente trabajan o por fundaciones con las que colaboran. Resultados: En total fueron intervenidos quirúrgicamente 1008 pacientes (78.75% de los vistos en consulta), con una media de edad de 6.9 años, 51% varones y 49% mujeres. Los 3 grupos principales de patologías atendidas fueron: fisuras labiopalatinas (31%), reconstrucción mamaria postmastectomía (24%) y quemaduras (17%). Conclusiones: A través de este trabajo La FILACP agradece a todos y cada uno de los cirujanos que participaron en esta III Jornada Altruista y reconoce a los que lo hicieron en campañas anteriores, da a conocer datos de la actividad quirúrgica realizada en esta ocasión y contribuye a difundir la vertiente reconstructiva de la especialidad y su importante contribución a la mejora de la calidad de vida de los pacientes más desfavorecidos

Background and objective: The Ibero Latinamerican Federation of Plastic Surgery (FILACP), as an international organization of Plastic, Aesthetic and Reconstructive Surgery specialists with a common language, encourages their collaboration in humanitarian campaigns where with their work in highly complex surgeries on patients in disadvantaged environments, try to improve their quality of life and their social integration. In this paper we present, as an example of the last years work, the activities developed by the teams enrolled in the III Plastic Surgery Altruist Campaign of FILACP in 2019. Methods: This campaign was convened from FILACP web, Fecebook and Youtube social networks and through letters sent to delegates in Social Medical and Communications Committees and to the presidents of national societies in the 22 member countries. The surgical working days were developed during July and August with teams composed by plastic surgeons, anesthesiologists and nursing staff who worked voluntarily, altruistically, and both in personal capacity or supported by the health institutions in which they usually work or by foundations with which they collaborate. Results: A total of 1008 patients were operated (78.75% of those visited in the consultation), with an average age of 6.9 years, 51% men and 49% women. The 3 main groups of attended pathologies were: lip and palate cleft (31%), post mastectomy breast reconstruction (24%) and burns (17%). Conclusions: With this paper FILACP wants to thank each and every surgeon who participated in this III Altruist Campaign and recognize those who did it in previous campaigns, presents data from surgical activity conducted this time and contributes to the knowledge of the reconstructive aspect of the specialty and its important contribution to the improvement of the quality of life of the most disadvantaged patients

Is Latin America Ready to Identify Anaplastic Large Cell Lymphoma in Breast Implants Patients? Regional Encounter During the National Plastic Surgery Meeting in Cancun, Mexico.

INTRODUCTION: Anaplastic large cell lymphoma associated with breast implants is receiving increased attention. Most cases have been reported in Europe, North America (USA and Canada), Australia and New Zealand. Fewer cases have been reported in Latin America (including Mexico), Africa and Asia. METHODS: This report was delivered during our national plastic surgery meeting in Cancun in May 2017. Before the meeting, two participants reviewed the literature. The review was performed using the following information sources: PubMed, Embase, Cochrane, Fisterra, Google Scholar and LILACS, with entries from 1980 to August 2015 in several languages (English, Spanish, French and Portuguese). The results were revealed during the meeting to the other participants. The consensus was divided into two parts. The first part included an open-ended question regarding the incidence and prevalence of the problem. The second part included clinical scenarios with different items that were rated by the participants. After this activity, accordance among the responses was evaluated. RESULTS: Seven cases were reported during the meeting (3 from Mexico, 3 from Chile and 1 from Argentina). Fifty percent of the participants reported consulting with guidelines and clinical centers to help with potential cases. Most agreed that further studies must be done in cases of chronic seroma where the capsule plays an important role. DISCUSSION: A current debate exists about the incidence of this problem in Latin America because we did not report the same number of cases as Europe, Australia or North America. More studies are required to determine the differences among reports in Latin America. CONCLUSION: Most representatives agreed that further studies must be done. Concern is increasing, and the problem is known. Other factors involved may be considered, and the problem must not be ignored. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis.

Recent studies have shown a relationship between lymphoma and breast implants. We performed a meta-analysis about this problem. We found 80 cases, 50 of which were reported in the United States (62.5%). The average age was 52 years. The average time between breast implant surgery and lymphoma was 11 years. Forty-one percent of the breast implants were silicone, 42.19% were saline and 15.8% were unknown. The coverage of the breast implants was texturized in 21.3% and unknown in 78%. The most common brands were McGhan and Mentor. In 72.6% of the cases, the brand was unknown. The clinical findings were seroma (67.33%), nodes (13.8%), mass (22.1%), other (11.7%) and unknown (32%). The most common surgical treatment was capsulectomy and breast implant removal. In 97% of the cases, ALK was negative and 3% were positive. The most common marker was CD30. The most common chemotherapy regimen was CHOP. Three patients died. Two of the patients had extracapsular extension of the disease and breast cancer history. Lymphoma related with the breast implant was a different type of lymphoma, and in most cases, it was less aggressive. The disease was confined to the capsule. Few patients developed aggressive disease, were extracapsular and showed bad prognosis.

Comentario al artículo"Revisión a 5 años de técnicas quirúrgicas y características de los implantes en 2876 mamoplastias de aumento consecutivas" / No disponible

No disponible